<unk>  has shown overall safety and tolerability profile with no cognitive/psychomotor impairment and no sedation worse than placebo, and cardiac safety, that is, no QT prolongation. The incidence of most commonly reported adverse events was comparable between the<unk>  and placebo groups, which confirms that<unk>  has a favourable safety profile. While experiments in pregnant animals showed no risk for the unborn, no such data are available in humans. It is not known whether<unk>  passes into the breast milk.
Ebastine
Clemastine
Azelastine
Pemirolast
Pentagastrin
Altretamine
Hydrastine
Seratrodast